Quantcast

Latest Apoptosis Stories

2014-04-04 12:18:55

Researchers from the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter, have found that an agent that inhibits mitochondrial division can overcome tumor cell resistance to a commonly used cancer drug, and that the combination of the two induces rapid and synergistic cell death. Separately, neither had an effect. These findings will be presented Monday at the annual meeting of the American Association for Cancer Research Annual Meeting 2014. "In our earlier...

2014-04-03 10:41:19

Findings may help develop targeted drug interventions and fight cancer and neurodegenerative diseases The molecular details of how zinc, an essential trace element of human metabolism, interacts with the enzyme caspase-3, which is central to apoptosis or cell death, have been elucidated in a new study led by researchers at Virginia Commonwealth University. The study is featured on the cover of the April issue of the journal Angewandte Chemie’s International Edition. Dysregulation of...

2014-03-27 13:03:27

As a result, the neighbors become harder to kill Cells usually self-destruct when irreparable glitches occur in their DNA. Programmed cell death, or apoptosis, helps insure that cells with damaged DNA do not grow and replicate to produce more mutated cells. Apoptosis thereby helps protect and insure the survival of the organism. At the GSA Drosophila Research Conference, TinTin Su, Ph.D., will report that a dying Drosophila melanogaster larvae cell alerts neighboring cells that they are...

2014-03-27 04:20:51

Studies Identify PI3K Pathway Combinations and MYC Driven Cancers SAN DIEGO and NEW TAIPEI CITY, Taiwan, March 27, 2014 /PRNewswire-iReach/ -- Senhwa Biosciences, Inc. announced today that results from research with its first-in-class Pol I inhibitor, CX-5461, will be presented at the 2014 American Association for Cancer Research (AACR) annual meeting held on April 5-9 in San Diego, CA. Prof. Ross Hannan and Prof. Rick Pearson of the Peter MacCallum Cancer Centre (PMCC) will present...

2014-03-26 04:21:14

HASSELT, Belgium, March 26, 2014 /PRNewswire/ -- Complix, a biopharmaceutical company focused on the discovery and development of Cell Penetrating Alphabodies(TM) (CPABs), a unique class of protein therapeutics that are active against intracellular disease targets, announces that its CEO Dr Mark Vaeck will present tomorrow at BioCapital Europe [http://www.biocapitaleurope.com/BioCapitalEurope/index.html ] 2014 in Amsterdam, the Netherlands (March 27th). Details of the...

2014-03-18 23:26:16

An international team of researchers say CARP-1 Functional Mimetics (CFMs) triggered the death of mesothelioma cells and blocked their ability to spread in laboratory tests. Raleigh, NC (PRWEB) March 18, 2014 Cancer Monthly is reporting on a newly-published study suggesting that compounds called CFMs might offer a better way to fight the treatment-resistant cancer, malignant pleural mesothelioma. The study entitled “CARP-1 Functional Mimetics Are a Novel Class of Small Molecule...

2014-03-14 23:04:14

Findings Shed Light On Cell Death Process, Drug's Toxicity Charlottesville, VA (PRWEB) March 14, 2014 A new discovery about how dying cells are removed from the body could have an unexpected and important benefit: allowing doctors to rehabilitate a powerful antibiotic now deemed too toxic for human use. Despite showing great initial promise, the antibiotic trovafloxacin was pulled from the market in the U.S. because of concerns about its toxicity. New research from the University of...

2014-02-27 23:34:46

Cancer prevention awareness and one’s cannabinoid system are the focus of this month’s health update from Publius and The Cannabis Papers: A citizen’s guide to cannabinoids (2011). February's highlighted message on the Bryan William Brickner Blog involves inflammation, the novel cannabinoid receptor GPR55, and their connection to apoptosis, programmed cancer cell death. Chicago, IL (PRWEB) February 27, 2014 “Turning cancer cells off (apoptosis) involves the cannabinoid...

2014-02-26 23:34:39

Cancer-Code Corporation announces the issuance of U.S. Patent No. 8,656,930: “Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy." Albuquerque, NM (PRWEB) February 26, 2014 Cancer-Code Corporation (C3) announces the issuance of U.S. Patent No. 8,656,930 on February 25, 2014. The ‘930 patent, entitled “Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy,” covers a breakthrough technological approach to...

2014-02-14 08:26:33

Clinical and Regulatory Plans for Two Lead Products Announced SAN DIEGO, Feb. 14, 2014 /PRNewswire/ -- MultiVir, a leader in gene therapies for cancer treatment, presented to the investment community at the Leerink Global Healthcare Conference. Highlights of the presentation included an overview of the development plans for the company's two lead products which are supported by strong pre-clinical and clinical data. MultiVir's adenoviral p53 (Ad-p53) and adenoviral interleukin 24...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related